(Q44594900)
English
A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A S
scientific article published in December 1998
Statements
1 reference
A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A S (English)
1 reference
Fischl MA
1 reference
Henry K
1 reference
Erice A
1 reference
Tierney C
1 reference
Balfour HH Jr
1 reference
Kmack A
1 reference
Liou SH
1 reference
Kenton A
1 reference
Hirsch MS
1 reference
Phair J
1 reference
Martinez A
1 reference
Kahn JO
1 reference
1 December 1998
1 reference
1 reference
19
1 reference
4
1 reference
339-349
1 reference
Identifiers
1 reference
1 reference